CanniMed Therapeutics Inc. Reports Financial Results for Q1 2017
March 16, 2017
SASKATOON, Saskatchewan–(BUSINESS WIRE)–CanniMed Therapeutics Inc. (“CanniMed” or the “Company”) (TSX: CMED) (OTC: CMMDF) today released its financial results for its first quarter ended January 31, 2017.
Our medical cannabis sales increased dramatically during the quarter, with
... read more at: https://www.newcannabisventures.com/cannimed-q1-sales-grow-8-from-q4/